BRPI0518405B8 - conjunto de esferas para detectar uma cepa de hpv e/ou para diferenciar entre duas ou mais cepas de hpv, método para preparar o conjunto de esferas, método para diagnosticar infecção por hpv em um sujeito humano, uso do conjunto de esferas e método para detectar e/ou para diferenciar entre duas ou mais cepas de hpv particulares em uma amostra biológica - Google Patents

conjunto de esferas para detectar uma cepa de hpv e/ou para diferenciar entre duas ou mais cepas de hpv, método para preparar o conjunto de esferas, método para diagnosticar infecção por hpv em um sujeito humano, uso do conjunto de esferas e método para detectar e/ou para diferenciar entre duas ou mais cepas de hpv particulares em uma amostra biológica

Info

Publication number
BRPI0518405B8
BRPI0518405B8 BRPI0518405A BRPI0518405A BRPI0518405B8 BR PI0518405 B8 BRPI0518405 B8 BR PI0518405B8 BR PI0518405 A BRPI0518405 A BR PI0518405A BR PI0518405 A BRPI0518405 A BR PI0518405A BR PI0518405 B8 BRPI0518405 B8 BR PI0518405B8
Authority
BR
Brazil
Prior art keywords
hpv
bead set
detecting
strains
differentiating
Prior art date
Application number
BRPI0518405A
Other languages
English (en)
Inventor
Poetter Karl
Gould Toby
Original Assignee
Genera Biosystems Pty Ltd
Genera Biosystems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004907070A external-priority patent/AU2004907070A0/en
Application filed by Genera Biosystems Pty Ltd, Genera Biosystems Ltd filed Critical Genera Biosystems Pty Ltd
Publication of BRPI0518405A2 publication Critical patent/BRPI0518405A2/pt
Publication of BRPI0518405B1 publication Critical patent/BRPI0518405B1/pt
Publication of BRPI0518405B8 publication Critical patent/BRPI0518405B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

detecção de vírus papiloma humano (hpv) utilizando sondas de ácido nucléico, microcontas e separador de células ativado fluorescente (facs). a presente invenção refere-se genericamente ao campo de ensaios de detecção e diagnóstico. mais particularmente, a presente invenção provê métodos e reagentes incluindo biochips para detectar a presença de, ou distinguir entre um ou mais analisados em uma amostra.
BRPI0518405A 2004-12-10 2005-12-09 conjunto de esferas para detectar uma cepa de hpv e/ou para diferenciar entre duas ou mais cepas de hpv, método para preparar o conjunto de esferas, método para diagnosticar infecção por hpv em um sujeito humano, uso do conjunto de esferas e método para detectar e/ou para diferenciar entre duas ou mais cepas de hpv particulares em uma amostra biológica BRPI0518405B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2004907070A AU2004907070A0 (en) 2004-12-10 Compositions and methods of detection
AU2004907070 2004-12-10
US70497405P 2005-08-03 2005-08-03
US60/704,974 2005-08-03
PCT/AU2005/001865 WO2006060872A1 (en) 2004-12-10 2005-12-09 Human papilloma virus (hpv) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (facs)

Publications (3)

Publication Number Publication Date
BRPI0518405A2 BRPI0518405A2 (pt) 2008-11-18
BRPI0518405B1 BRPI0518405B1 (pt) 2021-01-05
BRPI0518405B8 true BRPI0518405B8 (pt) 2021-07-27

Family

ID=36577611

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0518405A BRPI0518405B8 (pt) 2004-12-10 2005-12-09 conjunto de esferas para detectar uma cepa de hpv e/ou para diferenciar entre duas ou mais cepas de hpv, método para preparar o conjunto de esferas, método para diagnosticar infecção por hpv em um sujeito humano, uso do conjunto de esferas e método para detectar e/ou para diferenciar entre duas ou mais cepas de hpv particulares em uma amostra biológica

Country Status (9)

Country Link
US (2) US7901883B2 (pt)
EP (1) EP1833985B1 (pt)
JP (1) JP4974899B2 (pt)
AU (1) AU2005313858B2 (pt)
BR (1) BRPI0518405B8 (pt)
CA (1) CA2589912C (pt)
MX (1) MX2007006845A (pt)
NZ (1) NZ554229A (pt)
WO (1) WO2006060872A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1756548B1 (en) 2004-05-26 2015-06-24 Genera Biosystems Limited Biosensor using whispering gallery modes in microspheres
AU2005313858B2 (en) * 2004-12-10 2011-04-07 Genera Biosystems Limited Human papilloma virus (HPV) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (FACS)
JP2008196927A (ja) * 2007-02-13 2008-08-28 Fujifilm Corp プローブの脱着を伴う対象物質の検出方法
AU2008236678B2 (en) * 2007-04-05 2013-09-12 Genera Biosystems Limited Compositions and methods of detection
CA2686211C (en) * 2007-05-03 2018-08-21 One Lambda Inc. Methods of screening for binding interaction using sets of microparticles and unique probes
CN101487042B (zh) * 2008-01-18 2012-05-30 中山大学达安基因股份有限公司 Hpv高危和低危亚型分型dna微阵列芯片
US8282895B2 (en) * 2009-09-15 2012-10-09 Qiagen Gaithersburg, Inc. Reagent cabinet system
AU2012255683B2 (en) * 2011-05-13 2016-04-14 Adelaide Research & Innovation Pty Ltd A method of and a system for characterising a material
US9738941B2 (en) 2011-10-04 2017-08-22 Genera Biosystems Limited Compositions and methods of detecting respiratory pathogens using nucleic acid probes and subsets of beads
CN104459975B (zh) * 2014-12-29 2016-08-24 中国科学院长春光学精密机械与物理研究所 成像流式细胞仪的显微成像光学系统
US12252582B2 (en) 2019-08-29 2025-03-18 University Of Delaware Biofunctional thiophene monomers and polymers thereof for electronic biomedical devices
US11519040B2 (en) * 2020-12-22 2022-12-06 Poppy Health, Inc. System and method for detecting pathogens in an environment
CN113189059B (zh) * 2021-01-07 2023-03-28 西安交通大学 基于适配体和声表面波的病毒分选富集检测系统及方法
US20220341850A1 (en) * 2021-04-23 2022-10-27 Poppy Health, Inc. System and method for characterizing, monitoring, & detecting bioaerosol presence & movement in an indoor environment
US12540933B2 (en) 2021-12-07 2026-02-03 Poppy Health, Inc. System and method for characterizing, monitoring, and detecting bioaerosol presence and movement in an indoor environment
US12181401B2 (en) 2021-12-07 2024-12-31 Poppy Health, Inc. Tracer detection system and method for characterizing effectiveness of air removal in an aerosol zone
EP4435045A1 (en) * 2023-03-21 2024-09-25 COSA Group GmbH Labelled particles

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1276575C (fr) 1984-11-30 1990-11-20 Sylvie Beaudenon Sondes a papillomavirus et procede de diagnostic in vitro d'infections a papillomavirus
US5411857A (en) 1985-07-31 1995-05-02 Institut Nationale De La Sante Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections
US5876922A (en) 1985-07-31 1999-03-02 Institute Pasteur Papillomavirus probe and a process for in vitro diagnosis of papillomavirus infections
AU615159B2 (en) 1986-03-21 1991-09-26 F. Hoffmann-La Roche Ltd Determined dna sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
AU619170B2 (en) 1987-01-09 1992-01-23 Abbott Laboratories Diagnostic assays using nucleic acid probes
FR2629458B2 (fr) 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
US5639871A (en) 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
US5447839A (en) 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
CA1339729C (en) 1988-10-26 1998-03-17 Wayne D. Lancaster Human papillomavirus type 52 dna sequences and methods for employing thesame
US5580970A (en) 1989-12-01 1996-12-03 Amoco Corporation Detection of HPV transcripts
NL9000134A (nl) 1990-01-19 1991-08-16 Stichting Res Fonds Pathologie Primers en werkwijze voor het detecteren van humaan papilloma virus genotypen m.b.v. pcr.
US5484699A (en) 1990-09-28 1996-01-16 Abbott Laboratories Nucleotide sequences useful as type specific probes, PCR primers and LCR probes for the amplification and detection of human papilloma virus, and related kits and methods
FR2670797A1 (fr) 1990-12-20 1992-06-26 Pasteur Institut Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
US5346811A (en) 1991-07-22 1994-09-13 Cerveceria Polar Method and products for human papillomavirus detection
JP3659646B2 (ja) * 1994-02-21 2005-06-15 スティヒティング リサーチフォンズ パトロジー 普遍プライマーを用いる核酸増幅方法によるヒト乳頭腫ウィルス検出
CA2163393C (en) * 1994-11-30 2003-04-22 Colleen Marie Nycz Amplification and detection of mycobacteria nucleic acids
US5981180A (en) * 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
DE69638321D1 (de) 1995-10-11 2011-03-03 Luminex Corp Gleichzeitige mehrfachanalyse klinischer proben
CA2237891C (en) 1995-11-15 2013-07-30 Gen-Probe Incorporated Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits
US6511805B1 (en) 1996-03-15 2003-01-28 The Penn State Research Foundation Methods for detecting papillomavirus DNA in blood plasma and serum
US6265154B1 (en) 1996-10-25 2001-07-24 Abbott Laboratories Nucleic acid primers and probes for detecting oncogenic human papillomaviruses
DE69806024T2 (de) 1997-09-16 2003-02-13 Delft Diagnostic Laboratory B.V., Delft Erkennung und identifizierung von menschlichem papillomavirus durch pcr und typ-spezifischer reverser hybridisierung
ZA989950B (en) 1997-11-17 1999-05-04 Akzo Nobel Nv Transcription based amplification of double stranded DNA targets
WO2002024959A2 (en) * 2000-09-22 2002-03-28 Luminex Corporation Multiple reporter read-out for bioassays
WO2002039083A2 (en) * 2000-11-08 2002-05-16 Science & Technology Corporation @ Unm Fluorescence and fret based assays for biomolecules on beads
AU2002237662A1 (en) 2000-11-17 2002-05-27 Surromed, Inc. Analysis of soluble factor biological markers
PT1421200E (pt) 2001-08-23 2007-02-28 Merck & Co Inc Ensaios de pcr multiplex fluorescente para hpv usando múltiplos fluoróforos
KR100452163B1 (ko) * 2001-09-14 2004-10-12 주식회사 바이오메드랩 인유두종 바이러스의 감염을 진단하기 위한 유전형 분석키트
AU2002359645A1 (en) * 2001-12-07 2003-07-09 University Of Massachusetts Targeted genetic risk-stratification using microarrays
AU2002950953A0 (en) 2002-08-23 2002-09-12 Genera Biosystems Pty Ltd Coded nucleic acid carriers
KR100541916B1 (ko) * 2003-03-24 2006-01-10 바이오코아 주식회사 인유두종바이러스(ｈｐｖ)유전자형 분석용 서스펜션어레이 마이크로스피어 비드 조성물 및 그 검사 방법
AU2003903417A0 (en) * 2003-07-04 2003-07-17 Genera Biosystems Pty Ltd Multiplex detection
AU2005313858B2 (en) * 2004-12-10 2011-04-07 Genera Biosystems Limited Human papilloma virus (HPV) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (FACS)

Also Published As

Publication number Publication date
CA2589912C (en) 2019-03-05
AU2005313858B2 (en) 2011-04-07
EP1833985A1 (en) 2007-09-19
BRPI0518405A2 (pt) 2008-11-18
JP2008522592A (ja) 2008-07-03
AU2005313858A1 (en) 2006-06-15
EP1833985B1 (en) 2014-08-27
US20100015594A1 (en) 2010-01-21
US8389217B2 (en) 2013-03-05
US20110123978A1 (en) 2011-05-26
BRPI0518405B1 (pt) 2021-01-05
EP1833985A4 (en) 2009-07-29
NZ554229A (en) 2009-03-31
JP4974899B2 (ja) 2012-07-11
CA2589912A1 (en) 2006-06-15
US7901883B2 (en) 2011-03-08
WO2006060872A1 (en) 2006-06-15
MX2007006845A (es) 2007-10-23

Similar Documents

Publication Publication Date Title
BRPI0518405B8 (pt) conjunto de esferas para detectar uma cepa de hpv e/ou para diferenciar entre duas ou mais cepas de hpv, método para preparar o conjunto de esferas, método para diagnosticar infecção por hpv em um sujeito humano, uso do conjunto de esferas e método para detectar e/ou para diferenciar entre duas ou mais cepas de hpv particulares em uma amostra biológica
Liu et al. A microfluidic-integrated lateral flow recombinase polymerase amplification (MI-IF-RPA) assay for rapid COVID-19 detection
Song et al. Point-of-care testing detection methods for COVID-19
US10689716B1 (en) Materials and methods for detecting coronavirus
Kim et al. Current advances in paper-based biosensor technologies for rapid COVID-19 diagnosis
Choi et al. Sample-to-answer palm-sized nucleic acid testing device towards low-cost malaria mass screening
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
RU2713112C2 (ru) Способы и средства для диагностики гриппа
Meng et al. Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19
WO2013116513A3 (en) Direct detection of disease biomarkers in clinical specimens using cationic nanoparticle-based assays & versatile and green methods forsynthesis of anisotropic silver nanostructures
Delhaes et al. Contribution of molecular diagnosis to congenital toxoplasmosis
CN102409079A (zh) 一种新型传染病核酸快速检测试剂盒及其检测方法
BRPI0407299A (pt) Métodos para detectar um analito associado com o hiv, para determinar a relação de células t cd4+ para células t cd8+, e para detectar rna do hiv, em uma amostra de sangue
Jiang et al. Molecular recognition triggered aptazyme cascade for ultrasensitive detection of exosomes in clinical serum samples
Zhang et al. Recent advances of functional nucleic acid-based sensors for point-of-care detection of SARS-CoV-2
WO2017070419A1 (en) Mxa to drive increased specificity and augment sensitivity of bacterial biomarkers
BRPI0809958B8 (pt) conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico
Wang et al. Visual detection of COVID-19 from materials aspect
Veigas et al. Nanodiagnostics for tuberculosis
Zhu et al. Enhancing point-of-care diagnosis of African swine fever virus (ASFV) DNA with the CRISPR-Cas12a-assisted triplex amplified assay
CN102841199A (zh) 一种快速诊断流感的方法
US20170022547A1 (en) Amplification of nanoparticle based assay
Bellei et al. Evaluation of a rapid test (QuickVue) compared with the shell vial assay for detection of influenza virus clearance after antiviral treatment
Tanke et al. The use of upconverting phosphors in point-of-care (POC) testing
EP2444812A3 (en) Improved immunoassay methods

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: GENERA BIOSYSTEMS LIMITED (AU)

Free format text: ALTERADO DE: GENERA BIOSYSTEMS PTY LTD.

B25G Requested change of headquarter approved

Owner name: GENERA BIOSYSTEMS LIMITED (AU)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020090101611/RJ DE 29/10/2009.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/01/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/12/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2648 DE 05-10-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.